Company intelligence / Profile preview
Phoenix PharmaLabs
Woods Cross, Utah, United Statesphoenixpharmalabs.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Phoenix PharmaLabs is developing non-addictive pain therapies. Their lead compound PPL-138 has shown 100X potency of morphine with low risk of abuse/addiction and no respiratory depression in preclinical studies. Their second compound PPL-103 has demonstrated 10X potency of morphine, non-addictive properties, no withdrawal symptoms, no death from overdose (even at 350x the analgesic dose), and no constipation in animal studies. The company is completing final pre-clinical studies to seek IND approval from the FDA to initiate human clinical trials.
- Therapeutic areas
- DermatologyPsychiatryNeurology
- Modalities
- Small moleculesMorphinans
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
US Army Medical Research and Material Command (USAMRMC)NIH/NIDA (National Institute on Drug Abuse)
Beyond the preview
Go deeper on Phoenix PharmaLabs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phoenix PharmaLabs.